U.S. flag

An official website of the United States government

NM_000530.8(MPZ):c.703AAG[1] (p.Lys236del) AND Inborn genetic diseases

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jan 13, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002367719.3

Allele description [Variation Report for NM_000530.8(MPZ):c.703AAG[1] (p.Lys236del)]

NM_000530.8(MPZ):c.703AAG[1] (p.Lys236del)

Gene:
MPZ:myelin protein zero [Gene - OMIM - HGNC]
Variant type:
Microsatellite
Cytogenetic location:
1q23.3
Genomic location:
Preferred name:
NM_000530.8(MPZ):c.703AAG[1] (p.Lys236del)
HGVS:
  • NC_000001.11:g.161305917TCT[1]
  • NG_008055.1:g.9053AAG[1]
  • NM_000530.8:c.703AAG[1]MANE SELECT
  • NM_001315491.2:c.703AAG[1]
  • NP_000521.2:p.Lys236del
  • NP_001302420.1:p.Lys236del
  • LRG_256t1:c.706_708del
  • LRG_256:g.9053AAG[1]
  • NC_000001.10:g.161275705_161275707del
  • NC_000001.10:g.161275707TCT[1]
  • NC_000001.11:g.161305915_161305917delCTT
  • NM_000530.6:c.706_708delAAG
  • NM_000530.8:c.706_708delMANE SELECT
Protein change:
K236del
Links:
dbSNP: rs755446743
NCBI 1000 Genomes Browser:
rs755446743
Molecular consequence:
  • NM_000530.8:c.703AAG[1] - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001315491.2:c.703AAG[1] - inframe_deletion - [Sequence Ontology: SO:0001822]

Condition(s)

Name:
Inborn genetic diseases
Identifiers:
MeSH: D030342; MedGen: C0950123

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002662999Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Jan 13, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Charcot-Marie-Tooth neuropathy: clinical phenotypes of four novel mutations in the MPZ and Cx 32 genes.

Street VA, Meekins G, Lipe HP, Seltzer WK, Carter GT, Kraft GH, Bird TD.

Neuromuscul Disord. 2002 Oct;12(7-8):643-50.

PubMed [citation]
PMID:
12207932

Genotype-phenotype correlation in a family with late onset CMT and an MPZ lys236del mutation.

Sowden JE, Logigian EL, Malik K, Herrmann DN.

J Neurol Neurosurg Psychiatry. 2005 Mar;76(3):442-4.

PubMed [citation]
PMID:
15716547
PMCID:
PMC1739547
See all PubMed Citations (5)

Details of each submission

From Ambry Genetics, SCV002662999.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

The c.706_708delAAG (p.K236del) alteration is located in exon 6 (coding exon 6) of the MPZ gene. This alteration consists of an in-frame deletion of 3 nucleotides between nucleotide positions c.706 and c.708, resulting in the deletion of the lysine residue at codon 236. This alteration has been previously reported in multiple families with features of autosomal dominant, adult onset Charcot-Marie-Tooth disease; however, the phenotype reported in one family shows variable penetrance with symptoms ranging from being asymptomatic to having foot deformities, pedal numbness, and muscle cramps (Street, 2002; Sowden, 2005; Volodarsky, 2021). This amino acid position is highly conserved in available vertebrate species. Overall, functional studies suggest that the protein is mislocalized to the cytoplasm, alters protein-lipid interactions, and activates the unfolded protein response in vitro; however, additional evidence is needed to confirm these results (Bai, 2018; Raasakka, 2019). This alteration is predicted to be neutral by in silico analysis (Choi, 2012). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024